Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 195

Similar articles for PubMed (Select 21615222)

1.

Endoscopic grading of gastroesophageal flap valve helps predict proton pump inhibitor response in patients with gastroesophageal reflux disease.

Cheong JH, Kim GH, Lee BE, Choi MK, Moon JY, Ryu DY, Kim DU, Song GA.

Scand J Gastroenterol. 2011 Jul;46(7-8):789-96. doi: 10.3109/00365521.2011.579154. Epub 2011 May 26.

PMID:
21615222
2.

Endoscopic grading of gastroesophageal flap valve and atrophic gastritis is helpful to predict gastroesophageal reflux.

Kim GH, Song GA, Kim TO, Jo HJ, Kim do H, Heo J, Cho M, Kang DH.

J Gastroenterol Hepatol. 2008 Feb;23(2):208-14. doi: 10.1111/j.1440-1746.2007.05038.x.

PMID:
18289353
3.

The effect of gastroesophageal flap valve appearance on the management of patients with symptoms of gastroesophageal reflux disease.

Xirouchakis E, Kamberoglou D, Kalos D, Zambeli E, Doulgeroglou V, Tzias V.

Dig Dis Sci. 2009 Feb;54(2):328-32. doi: 10.1007/s10620-008-0347-2. Epub 2008 Jul 4.

PMID:
18600453
4.

Clinical predictors for response to proton pump inhibitor treatment in patients with globus.

Jeon HK, Kim GH, Choi MK, Cheong JH, Baek DH, Lee GJ, Lee HM, Lee BE, Song GA.

J Neurogastroenterol Motil. 2013 Jan;19(1):47-53. doi: 10.5056/jnm.2013.19.1.47. Epub 2013 Jan 8.

5.

Prospective evaluation of duodenogastroesophageal reflux in gastroesophageal reflux disease patients refractory to proton pump inhibitor therapy.

Kunsch S, Neesse A, Linhart T, Nell C, Gress TM, Ellenrieder V.

Digestion. 2012;86(4):315-22. doi: 10.1159/000342234. Epub 2012 Nov 1.

PMID:
23128301
6.

Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: a prospective pragmatic trial using pantoprazole.

Heading RC, Mönnikes H, Tholen A, Schmitt H.

BMC Gastroenterol. 2011 May 11;11:52. doi: 10.1186/1471-230X-11-52.

7.

Positive predictors for gastroesophageal reflux disease and the therapeutic response to proton-pump inhibitors.

Becker V, Grotz S, Schlag C, Nennstiel S, Beitz A, Haller B, Schmid RM, Meining A, Bajbouj M.

World J Gastroenterol. 2014 Apr 14;20(14):4017-24. doi: 10.3748/wjg.v20.i14.4017.

8.

Association of reflux symptom index scores with gastroesophageal flap valve status.

Kaplan M, Tanoglu A, Erkul E, Kara M, Yazgan Y.

Auris Nasus Larynx. 2014 Dec;41(6):543-7. doi: 10.1016/j.anl.2014.05.006. Epub 2014 Jun 2.

PMID:
24889495
9.

Gastroesophageal flap valve is associated with gastroesophageal and gastropharyngeal reflux.

Kim GH, Kang DH, Song GA, Kim TO, Heo J, Cho M, Kim JS, Lee BJ, Wang SG.

J Gastroenterol. 2006 Jul;41(7):654-61.

PMID:
16933002
10.

Proton-pump inhibitors in sleep-related breathing disorders: clinical response and predictive factors.

Modolell I, Esteller E, Segarra F, Mearin F.

Eur J Gastroenterol Hepatol. 2011 Oct;23(10):852-8. doi: 10.1097/MEG.0b013e328349d093.

PMID:
21811158
11.

Endoscopic grading of the gastroesophageal flap valve is correlated with reflux activity and can predict the size of the esophageal hiatus in patients with gastroesophageal reflux disease.

Koch OO, Spaun G, Antoniou SA, Rabl C, Köhler G, Emmanuel K, Öfner D, Pointner R.

Surg Endosc. 2013 Dec;27(12):4590-5. doi: 10.1007/s00464-013-3071-8. Epub 2013 Jul 12.

PMID:
23846367
12.

Abnormal gastroesophageal flap valve is highly associated with endoscopic reflux esophagitis after Helicobacter pylori eradication.

Takeuchi R, Kato K, Mizuno S, Kawamura Y, Kawamura F, Iwasaki A, Arakawa Y.

Helicobacter. 2004 Feb;9(1):1-8.

PMID:
15156898
13.

Predictors of response to short-term proton pump inhibitor treatment in laryngopharyngeal reflux patients.

Siupsinskiene N, Adamonis K, Toohill RJ, Sereika R.

J Laryngol Otol. 2008 Nov;122(11):1206-12. doi: 10.1017/S0022215108001898. Epub 2008 Mar 11.

PMID:
18331659
14.

Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs-TORNADO study: a multicenter prospective study by the Acid-Related Symptom Research Group in Japan.

Furuta T, Shimatani T, Sugimoto M, Ishihara S, Fujiwara Y, Kusano M, Koike T, Hongo M, Chiba T, Kinoshita Y; Acid-Related Symptom Research Group.

J Gastroenterol. 2011 Nov;46(11):1273-83. doi: 10.1007/s00535-011-0446-2. Epub 2011 Aug 24.

PMID:
21861141
15.

Is the proton pump inhibitor test helpful in patients with laryngeal symptoms?

Kim JH, Sung IK, Hong SN, Lee SY, Park HS, Shim CS.

Dig Dis Sci. 2013 Jun;58(6):1663-7. doi: 10.1007/s10620-012-2540-6. Epub 2013 Feb 27.

PMID:
23443492
16.
17.

A prospective study to compare a symptom-based reflux disease questionnaire to 48-h wireless pH monitoring for the identification of gastroesophageal reflux (revised 2-26-11).

Lacy BE, Chehade R, Crowell MD.

Am J Gastroenterol. 2011 Sep;106(9):1604-11. doi: 10.1038/ajg.2011.180. Epub 2011 Jun 21.

PMID:
21691342
18.

BMI is superior to symptoms in predicting response to proton pump inhibitor: randomised trial in patients with upper gastrointestinal symptoms and normal endoscopy.

Fletcher J, Derakhshan MH, Jones GR, Wirz AA, McColl KE.

Gut. 2011 Apr;60(4):442-8. doi: 10.1136/gut.2010.228064. Epub 2010 Dec 15.

PMID:
21159892
19.

Prevalence of and impact of pantoprazole on nocturnal heartburn and associated sleep complaints in patients with erosive esophagitis.

Kindt S, Imschoot J, Tack J.

Dis Esophagus. 2011 Nov;24(8):531-7. doi: 10.1111/j.1442-2050.2011.01189.x. Epub 2011 Mar 18.

PMID:
21418126
20.

Does Helicobacter pylori infection influence response rate or speed of symptom control in patients with gastroesophageal reflux disease treated with rabeprazole?

de Boer W, de Wit N, Geldof H, Hazelhoff B, Bergmans P, Smout A, Tytgat G.

Scand J Gastroenterol. 2006 Oct;41(10):1147-54.

PMID:
16990199
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk